Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction

American Heart Journal

Volumn 137, Issue 5, 1999, Pages 792-798

  Sadowski, Zygmunt P ^b   Alexander, John H ^a   Skrabucha, Bogdan ^b   Dyduszynski, Andrzej ^b   Kuch, Jerzy ^b   Nartowicz, Edmund ^b   Swiatecka, Grazyna ^b   Kong, David F ^b   Granger, Christopher B ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LIDOCAINE; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART DEATH; HEART VENTRICLE FIBRILLATION; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0032910534     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70401-1     Document Type: Article

References (29)

1. 1. Lown B, Fakhro AM, Hood WB, et al. The coronary care unit: new perspectives and directions. JAMA 1967;199:156-66.
2. 2. DeSilva RA, Lown B, Hennekens CH, et al. Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trials. Lancet 1981;2:855-8.
3. 3. Hine LK, Laird N, Hewitt P, et al. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med 1989;149:2694-8.
4. 4. MacMahon S, Collins R, Peto R, et al. Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from randomized, controlled trials. JAMA 1988; 260:1910-6.
5. 5. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 1993;270:1589-95.
6. 6. Ryan TJ, Anderson, JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol 1996;28:1328-428.
7. 7. Kostuk WJ, Beanlands DS. Prophylactic lidocaine in acute myocardial infarction. Circulation 1969;39(suppl III):111-125.
8. 8. Bennett MA, Wilner JM, Pentecost BL. Controlled trial of lignocaine in prophylaxis of ventricular arrhythmias complicating myocardial infarction. Lancet 1970;2:909-11.
9. 9. Mogensen L. Ventricular tachyarrhythmias and lignocaine prophylaxis in acute myocardial infarction. Acta Med Scand 1971;513:1-80.
10. 10. Baker IA, Collins JV, Evans TR. Prophylaxis of ventricular dysrhythmias following acute myocardial infarction: a double-blind trial of continuous intravenous infusion of lignocaine. Guys Hosp Rep 1971;120:1-7.
11. 11. Chopra MP, Thadani U, Portal RW, et al. Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial. Br Med J 1971;3:668-70.
12. 12. Pitt A, Lipp H, Anderson ST. Lignocaine given prophylactically to patients with acute myocardial infarction. Lancet 1971;1:612-5.
13. 13. Darby S, Bennett MA, Cruickshank JC, et al. Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias. Lancet 1972;1:817-9.
14. 14. O'Brien KP, Taylor PM, Croxson RS. Prophylactic lignocaine in hospitalized patients with acute myocardial infarction. Med J Aust Suppl 1973;2:36-7.
15. 15. Bleifeld W, Merx W, Heinrich KW, et al. Controlled trial of prophylactic treatment with lidocaine in acute myocardial infarction. Eur J Clin Pharmacol 1973;6:119-26.
16. 16. Lie KI, Wellens HJ, van Capelle FJ, et al. Lidocaine in the prevention of primary ventricular fibrillation: a double-blind, randomized study of 212 consecutive patients. N Engl J Med 1974;291:1324-6.
17. 17. Valentine PA, Frew JL, Mashford ML, et al. Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. N Engl J Med 1974;291:1327-31.
18. 18. Sandler G, Dey N, Amonkar J. Prophylactic intramuscular lidocaine in myocardial infarction. Curr Ther Res 1976;20:563-73.
19. 19. Singh JB, Kocot SL. A controlled trial of intramuscular lidocaine in the prevention of premature ventricular contractions associated with acute myocardial infarction. Am Heart J 1976;81:430-6.
20. 20. Lie KI, Liem KL, Louridtz WJ, et al. Efficacy of lidocaine in preventing primary ventricular fibrillation within 1 hour after a 300 mg intramuscular injection. Am J Cardiol 1978;42:486-8.
21. 21. Wennerblom B, Holmberg S, Ryden L, et al. Antiarrhythmic efficacy and side-effects of lidocaine given in the prehospital phase of acute myocardial infarction. Eur Heart J 1982;3:516-24.
22. 22. Dunn HM, McComb JM, Kinney CD, et al. Prophylactic lidocaine in the early phase of suspected myocardial infarction. Am Heart J 1985;110:353-62.
23. 23. Koster RW, Dunning AJ. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction. N Engl J Med 1985;313:1105-10.
24. 24. Hargarten K, Aprahamian C, Stueven HA, et al. Prophylactic lidocaine in the prehospital patient with chest pain of suspected cardiac origin. Ann Emerg Med 1986;8:881-5.
25. 25. Wyse G, Kellen J, Rademaker AW. Prophylactic versus selective lidocaine for early ventricular arrhythmias of myocardial infarction. J Am Coll Cardiol 1988;12:507-13.
26. 26. Hargarten K, Chapman PD, Stueven HA, et al. Prehospital prophylactic lidocaine does not favorably affect outcome in patients with chest pain. Ann Emerg Med 1990;19:1274-9.
27. 27. Eddy DM, Hasselblad V, Fast*Pro software for meta-analysis by the confidence profile method. New York: Academic Press; 1992.
28. 28. Hedges LV, Olkin I. Statistical methods for meta-analysis. Orlando, Fla: Academic Press; 1985. p 199-201.
29. 29. LeLorier J, Gregoire G, Benhaddad A, et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997;337:536-42.